🇺🇸 Amlodipine/Atorvastatin in United States

FDA authorised Amlodipine/Atorvastatin on 30 January 2004

Marketing authorisation

FDA — authorised 30 January 2004

  • Application: NDA021540
  • Marketing authorisation holder: PHARMACIA
  • Local brand name: CADUET
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Cardiovascular approved in United States

Frequently asked questions

Is Amlodipine/Atorvastatin approved in United States?

Yes. FDA authorised it on 30 January 2004.

Who is the marketing authorisation holder for Amlodipine/Atorvastatin in United States?

PHARMACIA holds the US marketing authorisation.